POPULARITY
Apparently it is okay to follow women into the restroom if you want something from them. Also, Ashish K. Jha, MD, MPH is a very important man. Matthew Dowd is very salty and what the hell happened to Facebook. Find us at www.burnbarrelpodcast.com Email us: burnbarrelpodcast@gmail.com Follow on Parler: @burnbarrelpodcast On Gab: @burnbarrelpodcast Facebook: facebook.com/burnbarrelpodcast And Twitter: @burnbarrelpod Rumble: rumble.com/c/burnbarrelpodcast YouTube: www.youtube.com/channel/UCWhLuhtutKdCmbHaWuGg_YQ Follow Tom on Twitter: @tomshattuck You can follow Alice too: @aliceshattuck More Tom stuff at www.tomshattuck.com Tom's "Insta" as the zoomers say: www.instagram.com/tomwshattuck/ Join us at Locals: burnbarrel.locals.com (subscriber based) Join us at Patreon: www.patreon.com/burnbarrel (subscriber based) The opening theme music is called Divine Intervention by Matthew Sweet. The closing theme music to this podcast C'est La Vie by Derek Clegg. Excelsior
When schools finished the academic year earlier this summer, they looked forward to the fall with the first cautious optimism anyone had felt in years. But Dr. Ashish Jha has offered level-headed wisdom that the pandemic simply is not over. Ashish K. Jha, MD, MPH, is a physician, health policy researcher, and the Dean of the Brown University School of Public Health. Before joining Brown, he was the K.T. Li Professor of Global Health at the Harvard T.H. Chan School of Public Health and Director of the Harvard Global Health Institute. An internationally respected and consulted pandemic expert, Jha strongly believes that communication with the public is an essential part of public health, and never more important than during a public-health emergency like COVID-19. He appears regularly on national news network shows, is active on social media, and is the authoritative voice on the “COVID: What Comes Next” podcast, available from The Providence Journal and the USA TODAY Network. In addition to his duties at Brown, maintains a clinical practice at the Providence VA Medical Center. See omnystudio.com/listener for privacy information.
The number of coronavirus infections is rising again as the delta variant becomes more dominant in the United States. Medical experts Ashish K. Jha, MD, and Céline Gounder, MD, join The Post to discuss the latest on the pandemic.
A practicing physician, Ashish K. Jha, M.D., MPH, is recognized globally as an expert on pandemic preparedness and response as well as on health policy research and practice. He joined to the Brown School of Public Health as Dean fter leading the Harvard Global Health Institute and teaching at the Harvard T.H. Chan School of Public Health and Harvard Medical School. Dr. Jha has published more than two hundred original research publications in prestigious journals such as the New England Journal of Medicine and the BMJ, and is a frequent contributor to a range of public media. He has extensively researched how to improve the quality and reduce the cost of health care, focusing on the impact of public health policy nationally and around the globe. Before joining the Brown School of Public Health, Dr. Jha was a faculty member at the Harvard T.H. Chan School of Public Health (HSPH) since 2004 and Harvard Medical School since 2005. He was the Faculty Director of the Harvard Global Health Institute from 2014 until September 2020. From 2018 to 2020, he served as the Dean for Global Strategy at the Harvard T.H. Chan School of Public Health. A general internist previously with the West Roxbury VA in Massachusettts, he practicea at the Providence VA Medical Center. Ashish was elected to the National Academy of Medicine in 2013. Follow him on twitter @ashishkjha Miriam Laufer MD is the Assistant Dean for Student Research and Education at University of Maryland School of Medicine Dr. Laufer is a pediatric infectious disease specialist, with a primary research interest in malaria and global child health. She has conducted research, clinical care and professional education in resource-limited countries in Africa and Asia, and has dedicated nearly two decades to working in Malawi. She and her research team use clinical and laboratory research to develop and evaluate interventions to decrease the burden of malaria in sub-Saharan Africa. She currently serves as Principal Investigator for clinical trials, epidemiological studies and a Fogarty training grant, that support her collaboration with colleagues throughout the US, Europe and Africa. In 2006, she published her first author paper Return of Chloroquine Antimalarial Efficacy in Malawi in the New England Journal of Medicine Dr. Laufer directs the Malaria Research Program at the Center for Vaccine Development and Global Health. The Malaria Research Program aims to support global malaria eradication efforts by developing and deploying innovative tools for improved malaria treatment, prevention and surveillance. Recognizing that progress requires interdisciplinary and international partnerships now and in the future, we work in collaboration with researchers across the globe and focus on training young scientists and clinical investigators to build research capacity both in the US and in malaria-endemic countries. Follow her on twitter @MirLaufer
Speaking at the 18th edition of the Hindustan Times Leadership Summit, Dr Ashish K. Jha, Dean, Brown University School of Public Health, commented on how our understanding of the Sars-CoV-2 virus has evolved over the past year. He said that although we understand the novel coronavirus in a much better fashion now than a few months ago, there's still a lot to be discovered. Dr Jha said that it is a 'far more complex disease than initially thought'.
Dr. Randeep Guleria, Director of AIIMS and Dr. Ashish K. Jha, Dean of Brown University School of Public Health spoke on the current Covid situation at the 18th edition of the Hindustan Times Leadership Summit 2020. Dr. Jha said that he is hopeful that no major outbreak will occur but warned that there will be several cases of minor outbreaks may be all through 2021. He added that the virus will be around for some time and added that with a vaccine we will learn to live with it in a way that it does not cause as much disruption. ‘This is a very smart virus. The more you learn about it, the more you admire it,’ said Dr. Randeep Guleria. He added that people will have to learn to live with the virus and be able to control it.
In the inaugural session of the Hindustan Times Leadership Summit 2020, Dr Ashish K. Jha, Dean, Brown University School of Public Health, spoke to R. Sukumar, editor-in-chief, Hindustan Times on the issue which will define the current year - the Covid-19 pandemic. Dr Jha shed light on the complicated link between immunity and the viral disease. He said that most people seem to develop immunity against Covid, and it lasts for around 8-9 months. A vaccine might improve this to a year.
The New York Post has published a story containing a series of emails that they claimed were evidence of Hunter Biden's foreign business dealings and the story is facing scrutiny since it was first posted. Editor and CEO of The Dispatch Stephen Hayes joins to discuss questions about the validity of the Post's story, how it may impact the 2020 election and what obstacles a new coronavirus stimulus relief bill may face in passing before the election day. As coronavirus cases are up in many parts of the country while entering fall and winter. The drug company Pfizer announces it expects to apply for federal approval for its vaccine in mid to late November. Dr. Ashish K. Jha, the dean of Brown University School of Public Health, discusses where we are at with a coronavirus vaccination, the possibility of rough winter and if there will be a full lockdown in the future. Commentary by Guy Benson, host of “The Guy Benson Show” Learn more about your ad choices. Visit megaphone.fm/adchoices
If you've followed sensible, expert advice on the pandemic, you've probably read or seen Ashish Jha in the New York Times, The Atlantic, CNN, Washington Post, and everywhere. On Tuesday he testified to the US Senate.He's Harvard's Global Health Institute's Director. Over 200,000 people have taken his online Harvard courses, which you can for free. Over 80,000 took Ebola, Preventing the Next Pandemic and over 120,000 took Improving Global Health: Focusing on Quality and Safety. As it turns out, we were college teammates on the ultimate frisbee team.I'll link to a few top articles by him. With so many interfaces between the pandemic and us---health, government, research, policy, etc---you can read a lot of his views and experiences from different sources.I wanted to bring the personal side of leading on the front lines and top levels of a pandemic---how do doctors and public health experts feel about people not following advice, facing triage decisions, how to be heard, and what affects a doctor personally. We talk about leadership, the intersection between the pandemic and the environment, which overlaps with his directorship and courses, and more.By the way, he created his Ebola course five years before this pandemic and predicted much of it, as did many. If predicting what's happened so far isn't enough reason to follow his advice, I don't know what is. Let's wear those masksAshish's faculty profileCoronavirus Testing Needs to Triple Before the U.S. Can Reopen, Experts Say, NY Times article quoting AshishIn the W.H.O.’s Coronavirus Stumbles, Some Scientists See a Pattern, NY Times article quoting Ashish Pandemic Expert Dr. Ashish K. Jha ’92: “We Will Get Through This.”How We Beat Coronavirus, The AtlanticHere's the reason we are still shut down right now, CNN video See acast.com/privacy for privacy and opt-out information.
Dr. Ashish K. Jha, head of the Harvard Global Health Institute, offers information on where we are where we’re going with the COVID-19 outbreak. Some take-aways: Communications missteps by the WHO regarding asymptomatic transmission have been quickly corrected. Yes, you can catch COVID-19 from people who are not showing symptoms. A second wave has begun, particularly in the south and Midwest. And calculations show we’ll reach more than 200,000 COVID-19 related deaths by September. Jha offers advice for parents, teachers and administrators on workable back-to-school scenarios. We know you don’t want to hear it, but COVID-19 will be a fact of global life for the rest of the year until a vaccine becomes widely available.
21 May 2020 The #COVID19 series continues.: Resa speaks with Ashish Jha MD MPH and Miriam Laufer MD MPH. They discuss the Atlantic magazine article ‘How Could the CDC Make That Mistake?', Hydroxychloroquine, Vaccines, Summer Camps, and opening institutions of higher learning (see NYTimes Op Ed by Christina Paxson) Dr. Ashish K. Jha is the K.T. Li Professor of Global Health at the Harvard TH Chan School of Public Health and Director of the Harvard Global Health Institute (HGHI). He is a practicing General Internist and is also Professor of Medicine at Harvard Medical School. Dr. Jha received his MD from Harvard Medical School and trained in Internal Medicine at the University of California in San Francisco. He completed his General Medicine fellowship at Brigham & Women's Hospital and received his MPH from the Harvard TH Chan School of Public Health. Dr. Jha is a member of the Institute of Medicine at the National Academies of Sciences, Engineering, and Medicine. In September, Dr. Jha will begin work as the Dean of the Brown University School of Public Health. Dr. Miriam Laufer is Professor of Pediatrics, Medicine, Epidemiology and Public Health, and Faculty of the graduate program in Microbiology and Immunology at the University of Maryland School of Medicine. She received her medical degree at the University of Pennsylvania and completed her residency in pediatrics at Babies and Children's Hospital of New York (now New York Children's Hospital) of Columbia University. She completed fellowships in pediatric infectious diseases at Johns Hopkins University and in malaria research at the Center for Vaccine Development at the University of Maryland. She received her MPH from the Bloomberg School of Public Health at Johns Hopkins University.
The COVID-19 outbreak has caused markets to collapse and worldwide health systems to become overwhelmed. When there’s a global pandemic, it’s nice to hear from the steady, transparent and yes even reassuring voice of experts on the front lines. We spoke to Dr. Ashish K. Jha, faculty director of the Harvard Global Health Institute. Dr. Jha’s recent appearance on the PBS Newshour caused reverberations throughout the federal and state response system. Here's his update.
In the second part of his keynote address at the 2019 AMA State Advocacy Summit, Ashish K. Jha, MD, MPH, director of Harvard Global Health Institute, talks about the tradeoff of positive and negative outcomes stemming from high prices in America’s health care sector. You can follow along with Dr. Jha by viewing his presentation deck at ama-assn.org/jha-mm and subscribe for exclusive advocacy news at ama-assn.org/advocacy-update.
In the first part of his keynote address at the 2019 AMA State Advocacy Summit, Ashish K. Jha, MD, MPH, director of Harvard Global Health Institute, discusses why the U.S. spends so much more on health care than other countries and reviews data on potential sources for this high spend. You can follow along with Dr. Jha by viewing his presentation deck at ama-assn.org/jha-mm and subscribe for exclusive advocacy news at ama-assn.org/advocacy-update.
Interview with Ashish K. Jha, MD, MPH, author of Comparison of Hospital Mortality and Readmission Rates for Medicare Patients Treated by Male vs Female Physicians, and Anna L. Parks, MD and Rita F. Redberg, MD, authors of Women in Medicine and Patient Outcomes
Interview with Ashish K. Jha, MD, MPH, author of Association Between Hospital Conversions to For-Profit Status and Clinical and Economic Outcomes
Interview with Donald S. Likosky, PhD, author of Growth in Medicare Expenditures for Patients With Acute Myocardial Infarction: A Comparison of 1998 Through 1999 and 2008, and Ashish K. Jha, MD, MPH, author of Going After the Money: Curbing the Rapid Growth in Medicare Expenditures for Medical Services More Than 30 Days After Hospital Admission